| Drug Name | Simulect (Basiliximab) |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Transplant
|
| Risk |
Warning for off-label use in cardiac transplantation |
| Dear Healthcare provider letter DHPC |
|